Entity Common Stock, Shares Outstanding of Nascent Biotech Inc. from 13 Feb 2015 to 28 Jun 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Nascent Biotech Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 13 Feb 2015 to 28 Jun 2024.
  • Nascent Biotech Inc. Entity Common Stock, Shares Outstanding for the quarter ending 28 Jun 2024 was 172,202,165, a 22% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Nascent Biotech Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 172,202,165 +30,800,637 +22% 28 Jun 2024 10-K 01 Jul 2024 2024 FY
Q4 2023 169,729,565 +45,244,296 +36% 14 Feb 2024 10-Q 14 Feb 2024 2024 Q3
Q3 2023 166,735,430 +47,173,820 +39% 09 Nov 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 141,401,528 +26,388,353 +23% 29 Jun 2023 10-K/A 03 Jul 2023 2023 FY
Q4 2022 124,485,269 +16,757,094 +16% 14 Feb 2023 10-Q 14 Feb 2023 2023 Q3
Q3 2022 119,561,610 +11,833,435 +11% 10 Nov 2022 10-Q 10 Nov 2022 2023 Q2
Q2 2022 115,013,175 +7,285,000 +6.8% 15 Jun 2022 10-K 15 Jun 2022 2022 FY
Q4 2021 107,728,175 +10,669,021 +11% 14 Feb 2022 10-Q 14 Feb 2022 2022 Q3
Q3 2021 107,728,175 04 Nov 2021 10-Q 04 Nov 2021 2022 Q2
Q2 2021 107,728,175 +59,457,538 +123% 08 Jul 2021 10-K 08 Jul 2021 2021 FY
Q4 2020 97,059,154 +60,898,284 +168% 09 Feb 2021 10-Q 09 Feb 2021 2021 Q3
Q2 2020 48,270,637 +14,775,167 +44% 22 Jun 2020 10-K 22 Jun 2020 2020 FY
Q4 2019 36,160,870 +3,991,272 +12% 11 Feb 2020 10-Q 11 Feb 2020 2020 Q3
Q2 2019 33,495,470 +4,952,175 +17% 12 Jul 2019 10-K 12 Jul 2019 2019 FY
Q4 2018 32,169,598 +4,907,792 +18% 13 Feb 2019 10-Q 13 Feb 2019 2019 Q3
Q3 2018 30,532,857 +3,391,081 +12% 02 Nov 2018 10-Q 05 Nov 2018 2019 Q2
Q2 2018 28,543,295 +4,496,606 +19% 29 Jun 2018 10-K 29 Jun 2018 2018 FY
Q4 2017 27,261,806 +5,326,249 +24% 30 Jan 2018 10-Q 31 Jan 2018 2018 Q3
Q3 2017 27,141,776 +5,296,661 +24% 03 Nov 2017 10-Q 03 Nov 2017 2018 Q2
Q2 2017 24,046,689 +2,279,124 +10% 29 Jun 2017 10-K 29 Jun 2017 2017 FY
Q4 2016 21,935,557 08 Feb 2017 10-Q 09 Feb 2017 2017 Q3
Q3 2016 21,845,115 +806,213 +3.8% 09 Nov 2016 10-Q 09 Nov 2016 2017 Q2
Q2 2016 21,767,565 +3,702,965 +20% 14 Jul 2016 10-K 14 Jul 2016 2016 FY
Q1 2016 21,501,115 19 Feb 2016 10-Q 19 Feb 2016 2016 Q3
Q3 2015 21,038,902 05 Nov 2015 10-Q 05 Nov 2015 2016 Q2
Q2 2015 18,064,600 02 Jul 2015 10-K 02 Jul 2015 2015 FY
Q4 2014 17,309,600 13 Feb 2015 10-Q 13 Feb 2015 2015 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.